Ocella
Product Images NDC 53002-1577

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Ocella (NDC 53002-1577). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 2 (7ae51f8c 8ea0 4502 8d7b D0c0b1a295ba 02)

A horizontal bar chart showing the number of women with a blood clot out of 10,000 women years (WY) for four categories: Non-Pregnant Non-COC user (range 1 to 5), COC-User (range 3 to 9), Pregnancy (range 5 to 20), and Postpartum (12 weeks only) with the highest range from 40 to 65. Pregnancy data is based on actual pregnancy duration and model assumptions are noted.*

FDA Label Image

Structural Formulas (7ae51f8c 8ea0 4502 8d7b D0c0b1a295ba 03)

Chemical structures of Drospirenone and Ethinyl estradiol, the active ingredients in OCELLA, are shown. The diagram displays the molecular formulas depicting the steroidal frameworks and functional groups characteristic to each compound.*

FDA Label Image

Pregnancy Diagram (7ae51f8c 8ea0 4502 8d7b D0c0b1a295ba 04)

An infographic diagram illustrating pregnancy rates corresponding to different birth control methods. It ranks methods from fewer pregnancies (less than 1 per 100 women per year) to more pregnancies (85 or more per 100 women per year). Methods shown include implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal ring with hormones, condoms, diaphragm, fertility awareness, spermicide, withdrawal, and no birth control.*

FDA Label Image

Ocella Foil (7ae51f8c 8ea0 4502 8d7b D0c0b1a295ba 05)

Medication blister pack for OCELLA by RPK Pharmaceuticals, Inc. It contains 28 circular tablets arranged in four rows labeled Week 1 to Week 4, with days Monday through Sunday indicated above each tablet. The active ingredients, drospirenone and ethinyl estradiol, are printed on the pack. The tablets for the first three weeks are shaded, while those in the fourth week are outlined but unshaded.*

FDA Label Image

Blood Clot Diagram (7ae51f8c 8ea0 4502 8d7b D0c0b1a295ba 06)

A horizontal bar chart depicting the number of women with a blood clot per 10,000 women years in four groups: Non-Pregnant Non-COC users (1 to 5), COC users (3 to 9), Pregnancy (5 to 20), and Postpartum (40 to 65). The x-axis represents the number of women with a blood clot out of 10,000 Women Years (WY).*

FDA Label Image

Fig 1 (Image 01)

A forest plot displaying hazard ratios, rate ratios, and odds ratios from various studies including Ingeinix, EURAS, LASS, FDA-funded, Danish, MEGA, German case-control, PharMetrics, and GPRD studies. The chart categorizes studies into prospective cohort, retrospective cohort, case-control, and non-fatal idiopathic cases, with a horizontal axis scaling from 0.1 to 10 on a logarithmic scale.*

FDA Label Image

Figure 3: Relative Studies Of Risk Of Breast Cancer With Combined Oral Contraceptives (Image 02)

A forest plot chart titled 'Relevant Studies of Risk of Breast Cancer with Combined Oral Contraceptives' comparing effect estimates of breast cancer risk between ever use or current use versus never use of combined oral contraceptives (COC). The chart plots odds ratios (OR), relative risks (RR), and hazard ratios (HR) with confidence intervals for various studies along a horizontal axis labeled 'Effect Estimate' ranging from -1.50 to 2.00.*

FDA Label Image

Label Image (Lbl530021577)

OCELLA 3.0/0.030 mg tablets 28-day regimen package label from RPK Pharmaceuticals, Inc. The label indicates a 1-month pack with instructions to take 1 tablet daily as directed. The package includes regulatory and billing information, a lot number, expiration date, and placeholders for clinic and patient information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.